Analysis of information sources in references of the Wikipedia article "Middle-of-the-night insomnia" in English language version.
Zaleplon (Sonata) is FDA approved for the short-term treatment of insomnia in adults. It has a very short half-life of 1 hour, making it particularly effective for initial insomnia. It also has a unique role as an as-needed medicine for middle-of-the-night insomnia.
Several other studies have also confirmed that zaleplon has little or no residual effects the following morning, even when taken during the middle of the night for the inability to go back to sleep.
Several other studies have also confirmed that zaleplon has little or no residual effects the following morning, even when taken during the middle of the night for the inability to go back to sleep.